219 related articles for article (PubMed ID: 10721498)
1. Substance use disorders in schizophrenia: review, integration, and a proposed model.
Blanchard JJ; Brown SA; Horan WP; Sherwood AR
Clin Psychol Rev; 2000 Mar; 20(2):207-34. PubMed ID: 10721498
[TBL] [Abstract][Full Text] [Related]
2. Borderline personality disorder and substance use disorders: a review and integration.
Trull TJ; Sher KJ; Minks-Brown C; Durbin J; Burr R
Clin Psychol Rev; 2000 Mar; 20(2):235-53. PubMed ID: 10721499
[TBL] [Abstract][Full Text] [Related]
3. [Dual diagnosis psychosis and substance use disorders in adolescents--part 1].
Meister K; Burlon M; Rietschel L; Gouzoulis-Mayfrank E; Bock T; Lambert M
Fortschr Neurol Psychiatr; 2010 Feb; 78(2):81-9. PubMed ID: 20146152
[TBL] [Abstract][Full Text] [Related]
4. Schizophrenia and substance use comorbidity: a genome-wide perspective.
Polimanti R; Agrawal A; Gelernter J
Genome Med; 2017 Mar; 9(1):25. PubMed ID: 28327175
[TBL] [Abstract][Full Text] [Related]
5. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes.
Dixon L
Schizophr Res; 1999 Mar; 35 Suppl():S93-100. PubMed ID: 10190230
[TBL] [Abstract][Full Text] [Related]
6. Management of schizophrenia with substance use disorders.
Lybrand J; Caroff S
Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
[TBL] [Abstract][Full Text] [Related]
7. Psychotic symptoms, self-harm and violence in individuals with schizophrenia and substance misuse problems.
Haddock G; Eisner E; Davies G; Coupe N; Barrowclough C
Schizophr Res; 2013 Dec; 151(1-3):215-20. PubMed ID: 24268935
[TBL] [Abstract][Full Text] [Related]
8. The co-occurrence of substance use in other mental disorders: editor's introduction.
Blanchard JJ
Clin Psychol Rev; 2000 Mar; 20(2):145-8. PubMed ID: 10721494
[TBL] [Abstract][Full Text] [Related]
9. [Negative symptoms in schizophrenia and substance-related disorders].
Simon N; Belzeaux R; Adida M; Azorin JM
Encephale; 2015 Dec; 41(6 Suppl 1):6S27-31. PubMed ID: 26776388
[TBL] [Abstract][Full Text] [Related]
10. Examining an affect regulation model of substance abuse in schizophrenia. The role of traits and coping.
Blanchard JJ; Squires D; Henry T; Horan WP; Bogenschutz M; Lauriello J; Bustillo J
J Nerv Ment Dis; 1999 Feb; 187(2):72-9. PubMed ID: 10067946
[TBL] [Abstract][Full Text] [Related]
11. Dual diagnosis: a review of etiological theories.
Mueser KT; Drake RE; Wallach MA
Addict Behav; 1998; 23(6):717-34. PubMed ID: 9801712
[TBL] [Abstract][Full Text] [Related]
12. The co-occurrence of bipolar and substance use disorders.
Strakowski SM; DelBello MP
Clin Psychol Rev; 2000 Mar; 20(2):191-206. PubMed ID: 10721497
[TBL] [Abstract][Full Text] [Related]
13. [Comorbidity of alcohol-substance use disorders in schizophrenia: a review].
Evren EC; Evren B
Turk Psikiyatri Derg; 2003; 14(3):213-24. PubMed ID: 14569472
[TBL] [Abstract][Full Text] [Related]
14. Substance misuse, psychiatric disorder and violent and disturbed behaviour.
Soyka M
Br J Psychiatry; 2000 Apr; 176():345-50. PubMed ID: 10827882
[TBL] [Abstract][Full Text] [Related]
15. Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders.
Xie H; McHugo GJ; Helmstetter BS; Drake RE
Schizophr Res; 2005 Jun; 75(2-3):337-48. PubMed ID: 15885525
[TBL] [Abstract][Full Text] [Related]
16. Schizophrenia and substance abuse: the interface.
Berti A
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):279-84. PubMed ID: 8208978
[TBL] [Abstract][Full Text] [Related]
17. Relationships between symptoms of schizophrenia and substance abuse.
Brunette MF; Mueser KT; Xie H; Drake RE
J Nerv Ment Dis; 1997 Jan; 185(1):13-20. PubMed ID: 9040528
[TBL] [Abstract][Full Text] [Related]
18. Neural correlates of the affect regulation model in schizophrenia patients with substance use history: a functional magnetic resonance imaging study.
Mancini-Marïe A; Potvin S; Fahim C; Beauregard M; Mensour B; Stip E
J Clin Psychiatry; 2006 Mar; 67(3):342-50. PubMed ID: 16649818
[TBL] [Abstract][Full Text] [Related]
19. Dual diagnosis among physicians: a clinical perspective.
Braquehais MD; Lusilla P; Bel MJ; Navarro MC; Nasillo V; Díaz A; Valero S; Padrós J; Bruguera E; Casas M
J Dual Diagn; 2014; 10(3):148-55. PubMed ID: 25392289
[TBL] [Abstract][Full Text] [Related]
20. Substance use disorder and schizophrenia: prevalence and sociodemographic characteristics in the Latin American population.
Jiménez-Castro L; Raventós-Vorst H; Escamilla M
Actas Esp Psiquiatr; 2011; 39(2):123-30. PubMed ID: 21404151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
